朗姿股份(002612.SZ):參股公司若羽臣IPO獲中證監核准批文
格隆匯 9 月 7日丨朗姿股份(002612.SZ)公佈,公司近日從公司重要參股公司廣州若羽臣科技股份有限公司(“若羽臣”)獲悉,若羽臣於2020年9月4日收到中國證券監督管理委員會下發的《關於核准廣州若羽臣科技股份有限公司首次公開發行股票的批覆》(證監許可[1648]號),證監會核准了若羽臣首次公開發行A股股票申請事項,若羽臣將根據中國證券監督管理委員會及證券交易所的相關規定組織發行工作。
公司於2015年參股若羽臣,目前持有若羽臣1500萬股股份,佔其首次公開發行前總股本的比例為16.43%。公司須遵守若羽臣首次公開發行股票(A股)招股説明書中披露的股東所持股份的流通限制、股東對所持股份自願鎖定的承諾。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.